PRESS RELEASE published on 07/27/2023 at 13:05, 1 year 8 months ago Metalite Resources Announces Resignation of David Kol from Board of Directors; Commences Strategic Review
PRESS RELEASE published on 06/20/2023 at 14:00, 1 year 9 months ago Metalite Resources Announces Appointment of an Expert in LCT Pegmatites to Its Advisory Board
PRESS RELEASE published on 05/30/2023 at 14:00, 1 year 10 months ago Metalite Provides Update on Its Lithium Exploration Activities in Liberia
PRESS RELEASE published on 05/10/2023 at 14:00, 1 year 10 months ago Metalite Announces the Appointment of Mario A. Miranda to the Board of Directors
PRESS RELEASE published on 05/02/2023 at 14:30, 1 year 11 months ago Metalite Provides an Update on Its Recent Acquisition of Next Generation Resources and Exploration Strategy
PRESS RELEASE published on 05/01/2023 at 13:00, 1 year 11 months ago Metalite Resources Engages TD Media LLC
PRESS RELEASE published on 03/22/2023 at 13:45, 2 years ago RooGold Announces Change of Name and Trading Symbol
PRESS RELEASE published on 03/20/2023 at 13:20, 2 years ago RooGold Announces Appointment of CEO and Changes to the Board of Directors
PRESS RELEASE published on 02/22/2023 at 14:30, 2 years 1 month ago RooGold Completes Acquisition of NextGen Adding Battery Metals Optionality In Resource-Rich Liberia to Its Precious Metals Portfolio in Australia
PRESS RELEASE published on 01/31/2023 at 13:30, 2 years 2 months ago RooGold Announces Appointment of Efdal Olcer as VP Exploration and Provides Operational Update
Published on 04/09/2025 at 14:30, 10 minutes ago Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Published on 04/09/2025 at 14:15, 25 minutes ago Revolve Corporate Update Highlights Several Key Milestones
Published on 04/09/2025 at 14:00, 40 minutes ago Bausch Health, Canada Inc. et l’Alliance pharmaceutique pancanadienne signent une lettre d’intention concernant pour la couverture par les régimes publics d’assurance médicaments du traitement pour l’acné vulgaire (Pr)CABTREO(MC) (gel de phosph
Published on 04/09/2025 at 14:00, 40 minutes ago Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
Published on 04/09/2025 at 13:45, 55 minutes ago Quartz Commences Drilling at Prodigy High Grade Precious Metals Discovery on Its Maestro Property in British Columbia
Published on 04/09/2025 at 14:10, 30 minutes ago Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/09/2025 at 11:26, 3 hours 14 minutes ago EQS-Adhoc: fox e-mobility AG: Resumption of trading – No challenge to capital resolutions – Legal remedy against the opening of bankruptcy proceedings at the Swiss subsidiary -
Published on 04/09/2025 at 11:24, 3 hours 16 minutes ago Electricité de Strasbourg - Avis de réunion AGO du 14 mai 2025 publié au BALO
Published on 04/09/2025 at 09:00, 5 hours 40 minutes ago STEF : Avis de mise à disposition des comptes annuels 2024
Published on 04/09/2025 at 08:00, 6 hours 40 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
Published on 04/09/2025 at 08:00, 6 hours 40 minutes ago Museum Studio devient actionnaire majoritaire de Lord Cultural Resources
Published on 04/09/2025 at 07:00, 7 hours 40 minutes ago Biophytis confirme le lancement de l’essai clinique de Phase 2 OBA dans l’obésité
